Location History:
- Koln, DE (1994 - 2000)
- Cologne, DE (1994 - 2003)
- Köln, DE (2003)
Company Filing History:
Years Active: 1994-2003
Title: Michael Grosse-Bley: Innovating in Pharmaceutical Formulations
Introduction
Michael Grosse-Bley is a prominent inventor based in Cologne, Germany. With a remarkable portfolio of 11 patents, he has made significant contributions to the field of pharmaceutical science, particularly in the formulation of injectable products. His work showcases a blend of creativity and scientific rigor, making him a notable figure within the industry.
Latest Patents
Among his latest innovations are the injectable formulations of avermectins and milbemycins. This patent focuses on unique injection formulations that utilize a solvent mixture comprising sesame oil, medium-chain triglycerides, glycol esters, or fatty acid esters, combined with other solvents such as mono- or polyhydric aliphatic or aromatic alcohols and their derivatives. This advancement aims to improve the delivery of these pharmaceuticals, enhancing their effectiveness for various applications.
Another noteworthy patent involves polymers chromatographic separation of enantiomers. This invention introduces novel optically active polymerizable dipeptides and details the processes for their preparation and polymerization. The resulting polymers serve as effective adsorbents for the chromatographic separation of enantiomers, showcasing Grosse-Bley's innovation in improving drug development processes.
Career Highlights
Michael Grosse-Bley is currently employed at Bayer Aktiengesellschaft, a leading global enterprise in the pharmaceutical and life sciences sector. His work contributes to Bayer’s mission of advancing healthcare through innovative solutions. Over the years, he has developed multiple patented technologies that not only enhance existing drug formulations but also pave the way for new therapeutic options.
Collaborations
Throughout his career, Grosse-Bley has collaborated with esteemed colleagues such as Rolf Grosser and Walter Lange. These partnerships have fostered a creative environment where innovative ideas can thrive, further propelling advancements in drug formulations and separations technology.
Conclusion
In conclusion, Michael Grosse-Bley stands out as a significant inventor whose work in the pharmaceutical domain continues to push the boundaries of innovation. His patents, particularly related to injectable formulations and chromatographic processes, reflect a commitment to enhancing the efficacy and safety of medical treatments. As he continues to innovate at Bayer Aktiengesellschaft, Grosse-Bley's contributions will undoubtedly play a crucial role in the future of healthcare.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.